Delivery Order SPE2DB25D3504-SPE2DB25FVTMH

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract has a ceiling value of $6,782.94 and a completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,989.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide brimonidine tartrate 0.1% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.36 Firm Fixed Price Delivery Order is for the supply of Brimonidine Tartrate 0.15% eye drops, with a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Brimonidine Tartrate 0.15% eye drops, a medication used to treat increased eye pressure. The contract has a ceiling value of $5,574.52 and a period of performance through January 2, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,008.76 and is for the procurement of BRIMONIDINE TARTRATE 0.15% DRP 5ML, a specialized eye drop medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery...
This federal contract award, with the ID SPE2DB22D1052|SPE2DB24FU8LR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops in 5 ml bottles. The contract is a Firm-Fixed-Price Delivery Order with a ceiling value of $4,459.28 and an ultimate completion date of February 12, 2024. The contract was not set aside for any specific business category....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,313.23 firm fixed-price delivery order is for the supply of 10 ml bottles of the medication Brimonidine-Timolol 0.2%-0.5%. The contract has a completion date of November 29, 2023 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical....
This contract award, with ID SPE2DB20D3103|SPE2DB23FM6W3, is for the delivery of Brimonidine Tartrate 0.15% ophthalmic drops in 15ml bottles to the Defense Logistics Agency (DLA). The $6,753.71 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on March 7, 2023 with a completion date of March 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVTMH
    Delivery Order

This federal contract award is for the delivery of brimonidine tartrate 0.15% eye drops with a ceiling value of $2,654.64. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. The awarded contract has an ultimate completion date of February 19, 2025.

Generated 5/22/25, 8:20 PM